Peter Stenvinkel

Peter Stenvinkel's AcademicInfluence.com Rankings

Peter Stenvinkel

Biology

#4669

World Rank

#6941

Historical Rank

Biotechnology

#31

World Rank

#32

Historical Rank

Cell Biology

#120

World Rank

#125

Historical Rank

Molecular Biology

#376

World Rank

#383

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Peter Stenvinkel Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Stenvinkel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. (1999) (1706)
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. (2008) (1570)
Review on uremic toxins: classification, concentration, and interindividual variability. (2003) (1398)
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. (2002) (1146)
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. (2005) (847)
Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). (2000) (820)
Aspects of immune dysfunction in end-stage renal disease. (2008) (813)
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. (2003) (748)
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). (2013) (625)
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy (2017) (580)
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008) (553)
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. (2006) (500)
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. (2013) (499)
Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and Therapy (2002) (436)
The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter. (2002) (419)
Associations between circulating inflammatory markers and residual renal function in CRF patients. (2003) (408)
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. (2002) (396)
Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? (2007) (379)
Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. (2014) (350)
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. (2005) (343)
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease (2010) (316)
Inflammation in End‐Stage Renal Disease—What Have We Learned in 10 Years? (2010) (303)
Chronic kidney disease and premature ageing (2014) (281)
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. (2007) (276)
Genetic loci influencing kidney function and chronic kidney disease (2010) (266)
Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. (2000) (262)
Uremic Toxicity: Present State of the Art (2001) (258)
Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy. (2016) (257)
Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. (2019) (251)
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. (2003) (247)
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. (2008) (245)
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. (2006) (232)
Wasting in chronic kidney disease (2011) (231)
Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. (2007) (231)
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease (2016) (225)
Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? (2002) (224)
Chronic kidney disease: a clinical model of premature aging. (2013) (220)
Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. (1997) (218)
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? (2002) (216)
J-shaped mortality relationship for uric acid in CKD. (2006) (216)
Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient (2000) (215)
Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. (2008) (209)
A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. (2002) (208)
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. (2000) (201)
Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. (2002) (197)
Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. (2002) (196)
Inflammation in end‐stage renal disease: The hidden enemy (Review Article) (2006) (195)
Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. (2000) (194)
Truncal fat mass as a contributor to inflammation in end-stage renal disease. (2004) (193)
Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. (2005) (190)
Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. (2004) (189)
Chronic inflammation in end-stage renal disease and dialysis (2018) (187)
Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. (2009) (185)
Inflammation in end-stage renal failure: could it be treated? (2002) (185)
Screening for muscle wasting and dysfunction in patients with chronic kidney disease. (2016) (182)
Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. (2000) (181)
Diets and enteral supplements for improving outcomes in chronic kidney disease (2011) (176)
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease (2007) (175)
Low serum testosterone increases mortality risk among male dialysis patients. (2009) (170)
Telomere attrition is associated with inflammation, low fetuin‐A levels and high mortality in prevalent haemodialysis patients (2008) (170)
Obesity in CKD--what should nephrologists know? (2013) (168)
Low leptin gene expression and hyperleptinemia in chronic renal failure. (1998) (168)
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD (2017) (167)
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. (2007) (166)
Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. (2005) (162)
Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. (2016) (156)
Serum albumin as predictor of nutritional status in patients with ESRD. (2012) (155)
Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. (2013) (153)
Systemic consequences of poor oral health in chronic kidney disease patients. (2011) (152)
The role of inflammation in the anaemia of end-stage renal disease. (2001) (152)
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. (2011) (148)
Inflammation and premature aging in advanced chronic kidney disease. (2017) (146)
Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. (2001) (145)
Endothelial dysfunction and inflammation-is there a link? (2001) (144)
Malnutrition and Chronic Inflammation as Risk Factors for Cardiovascular Disease in Chronic Renal Failure (2000) (143)
Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. (2014) (143)
Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease (2004) (139)
Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. (2003) (139)
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. (2003) (138)
Sarcopenia in chronic kidney disease: what have we learned so far? (2020) (136)
Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. (2016) (134)
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. (2003) (133)
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. (2016) (133)
Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. (2007) (127)
Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. (2010) (127)
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. (2007) (127)
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. (2008) (124)
Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. (2005) (123)
Why cachexia kills: examining the causality of poor outcomes in wasting conditions (2013) (123)
Adipose tissue and its relation to inflammation: the role of adipokines. (2005) (121)
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. (2004) (121)
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. (2008) (118)
Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. (2005) (118)
Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. (2005) (117)
Inflammation as a risk factor and target for therapy in chronic kidney disease (2011) (116)
Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure? (1999) (116)
Monitoring of inflammation in patients on dialysis: forewarned is forearmed (2011) (116)
Inflammation and nutrition in renal insufficiency. (2003) (115)
Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. (2009) (115)
Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. (2009) (115)
End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes. (2017) (113)
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification. (2015) (112)
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. (2008) (112)
Inflammation in end-stage renal disease--a fire that burns within. (2005) (110)
Malnutrition, Inflammation, and Atherosclerosis in Peritoneal Dialysis Patients (2001) (109)
Influence of Peritoneal Transport Rate, Inflammation, and Fluid Removal on Nutritional Status and Clinical Outcome in Prevalent Peritoneal Dialysis Patients (2003) (109)
Systemic and Intraperitoneal Interleukin-6 System during the First Year of Peritoneal Dialysis (2006) (108)
Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. (2011) (107)
Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. (2011) (106)
Chronic Inflammation in Peritoneal Dialysis: The Search for the Holy Grail? (2004) (105)
Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. (1997) (103)
Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It? (2008) (102)
Therapeutics targeting persistent inflammation in chronic kidney disease. (2016) (99)
Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. (2002) (99)
PROGRESS IN UREMIC TOXIN RESEARCH: The Role of Oxidative Stress in Chronic Kidney Disease (2009) (97)
High cardiovascular event rates occur within the first weeks of starting hemodialysis (2015) (97)
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. (2012) (97)
High cardiovascular event rates occur within the first weeks of starting hemodialysis (2015) (97)
Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease. (2004) (97)
Appetite disorders in uremia. (2008) (95)
Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. (2012) (94)
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. (2005) (93)
High Mobility Group Box Protein-1 Correlates with Renal Function in Chronic Kidney Disease (CKD) (2008) (92)
Low Serum Uric Acid Level Is a Risk Factor for Death in Incident Hemodialysis Patients (2008) (89)
Inflammation and wasting in chronic kidney disease: Partners in crime (2006) (89)
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness (2009) (89)
Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients. (2016) (89)
Cytokine gene polymorphism and progression of renal and cardiovascular diseases. (2007) (88)
PROGRESS IN UREMIC TOXIN RESEARCH: Cytokines, Atherogenesis, and Hypercatabolism in Chronic Kidney Disease: A Dreadful Triad (2009) (87)
A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. (1998) (87)
Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease (2019) (87)
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease (2018) (86)
ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. (2008) (86)
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. (2005) (84)
Homocysteine in uraemia--a puzzling and conflicting story. (2005) (83)
Soluble leptin receptors and serum leptin in end‐stage renal disease: relationship with inflammation and body composition (2002) (82)
Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. (2009) (82)
Update on interleukin-6 and its role in chronic renal failure. (2003) (81)
Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. (2010) (81)
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. (2012) (80)
Food as medicine: targeting the uraemic phenotype in chronic kidney disease (2020) (80)
The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. (2004) (80)
The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. (2012) (79)
Inflammation and Premature Ageing in Chronic Kidney Disease (2020) (79)
Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients (2004) (78)
Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease. (2003) (78)
Inflammation and oxidative stress in ESRD--the role of myeloperoxidase. (2004) (77)
Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. (2000) (77)
CCR5 deletion protects against inflammation-associated mortality in dialysis patients. (2009) (77)
Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. (1998) (76)
Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria. (2009) (76)
Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. (2014) (76)
The role of epigenetics in renal ageing (2017) (76)
Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients. (2011) (75)
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. (2006) (74)
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? (2010) (73)
Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. (2006) (73)
Risk Factors for Cardiovascular Disease in Patients Undergoing Peritoneal Dialysis (2007) (72)
Resveratrol: Why Is It a Promising Therapy for Chronic Kidney Disease Patients? (2013) (72)
Novel treatment strategies for chronic kidney disease: insights from the animal kingdom (2018) (71)
C-Reactive Protein in End-Stage Renal Disease: Are There Reasons to Measure It? (2004) (70)
The importance of diabetic nephropathy in current nephrological practice. (2003) (69)
Inflammation, Malnutrition and Atherosclerosis in End-Stage Renal Disease: A Global Perspective (2002) (69)
High serum hyaluronan indicates poor survival in renal replacement therapy. (1999) (69)
Hemoglobin variability does not predict mortality in European hemodialysis patients. (2010) (68)
The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. (2008) (67)
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. (2008) (67)
Serum Fetuin-A Concentration and Endothelial Dysfunction in Chronic Kidney Disease (2008) (66)
Chronic Systemic Inflammation in Dialysis Patients: An Update on Causes and Consequences (2004) (66)
Lipoprotein(a) in nephrotic syndrome. (1993) (66)
Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. (2012) (65)
Inflammation and Protein-Energy Wasting in the Uremic Milieu. (2017) (65)
Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy. (2004) (65)
Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. (2006) (65)
New insights on inflammation in chronic kidney disease-genetic and non-genetic factors. (2006) (65)
Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis. (2019) (65)
Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. (2004) (64)
Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality (2003) (64)
Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects (1992) (64)
Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. (2013) (63)
Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. (2008) (62)
Metabolic and Kidney Diseases in the Setting of Climate Change, Water Shortage, and Survival Factors. (2016) (62)
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism. (2018) (61)
Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. (1996) (60)
Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. (2011) (60)
Redefining Metabolic Syndrome as a Fat Storage Condition Based on Studies of Comparative Physiology (2012) (60)
Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging. (2004) (59)
Does statins promote vascular calcification in chronic kidney disease? (2017) (59)
Role of fat mass and adipokines in chronic kidney disease (2008) (58)
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. (2002) (58)
Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease (2019) (58)
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2 (2021) (57)
Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. (2008) (56)
Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients (2017) (56)
Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients (2005) (56)
Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation (2009) (56)
Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. (2004) (55)
Low serum fetuin‐A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients (2008) (55)
Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. (2011) (55)
Serum testosterone levels and clinical outcomes in male hemodialysis patients. (2014) (55)
Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. (2003) (55)
Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study (2019) (53)
Molecular studies of leptin: implications for renal disease. (1999) (53)
Adverse Pregnancy Outcomes and Long-term Maternal Kidney Disease: A Systematic Review and Meta-analysis. (2020) (53)
The emerging pleiotrophic role of adipokines in the uremic phenotype (2010) (52)
Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. (2007) (52)
The relationship between IL-10 levels and cardiovascular events in patients with CKD. (2014) (52)
Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach. (2008) (52)
Anaemia and inflammation: what are the implications for the nephrologist? (2003) (52)
Clinical importance of an elevated circulating chemerin level in incident dialysis patients. (2010) (52)
Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients (2015) (51)
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. (2010) (51)
Fructose metabolism as a common evolutionary pathway of survival associated with climate change, food shortage and droughts (2020) (51)
Klotho, Aging, and the Failing Kidney (2020) (51)
Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study. (2020) (50)
Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage? (2009) (50)
Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients. (2012) (50)
Increased expression of pro‐inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients (2011) (50)
Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction (2013) (50)
POOR NUTRITIONAL STATUS AND INFLAMMATION: Novel Approaches in an Integrated Therapy of Inflammatory‐Associated Wasting in End‐Stage Renal Disease (2004) (49)
PROGRESS IN UREMIC TOXIN RESEARCH: Hyperhomocysteinemia in Uremia—A Red Flag in a Disrupted Circuit (2009) (48)
Bone alkaline phosphatase: an important biomarker in chronic kidney disease - mineral and bone disorder. (2019) (48)
Adipose tissue and inflammation in chronic kidney disease. (2006) (48)
The complex role of adiponectin in chronic kidney disease. (2012) (48)
Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. (2015) (48)
Leptin and Its Clinical Implications in Chronic Renal Failure (1999) (48)
CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease (2017) (48)
Metabolic Changes in Summer Active and Anuric Hibernating Free-Ranging Brown Bears (Ursus arctos) (2013) (48)
Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? (1999) (47)
Circulating markers of ageing and allostatic load: A slow train coming☆ (2016) (47)
Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences. (2007) (47)
Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4. (2014) (47)
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. (2004) (46)
Leptin--a new hormone of definite interest for the nephrologist. (1998) (46)
MicroRNAs in AKI and Kidney Transplantation. (2019) (46)
Development and validation of cardiovascular risk scores for haemodialysis patients. (2016) (46)
Red meat intake in chronic kidney disease patients: Two sides of the coin. (2018) (46)
Correlation of computed tomography with carotid plaque transcriptomes associates calcification with lesion-stabilization. (2019) (45)
Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss (2014) (45)
End‐stage renal disease – not an equal opportunity disease: the role of genetic polymorphisms (2005) (44)
Impact of Residual Renal Function on Volume Status in Chronic Renal Failure (2004) (44)
Chronic kidney disease and inflammation in pediatric patients: from bench to playground (2005) (44)
Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease (2020) (44)
Accelerated ageing and renal dysfunction links lower socioeconomic status and dietary phosphate intake (2016) (44)
Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease? (2006) (43)
Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. (2004) (43)
Hibernating bears (Ursidae): metabolic magicians of definite interest for the nephrologist. (2013) (43)
Polymorphisms in cytokine genes influence long‐term survival differently in elderly male and female patients (2007) (43)
Curcumin - A promising nutritional strategy for chronic kidney disease patients (2018) (43)
Leptin, ghrelin, and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease? (2003) (42)
The Role of the TGF/Smad Signaling Pathway in Peritoneal Fibrosis Induced by Peritoneal Dialysis Solutions (2008) (42)
Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2—lessons from evolution, the animal kingdom and rare progeroid syndromes (2019) (42)
Leptin and blood pressure--is there a link? (2000) (42)
Oxidative DNA Damage and Mortality in Hemodialysis and Peritoneal Dialysis Patients (2015) (42)
Genetic and environmental risk factors for chronic kidney disease. (2017) (42)
Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients. (2013) (41)
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. (2006) (41)
Kidney insufficiency and nutrient-based modulation of inflammation (2005) (41)
Interleukin-6 Is a Better Predictor of Mortality as Compared to C-Reactive Protein, Homocysteine, Pentosidine and Advanced Oxidation Protein Products in Hemodialysis Patients (2008) (40)
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients. (2016) (40)
Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage (2020) (40)
Obesity and nephrology: results of a knowledge and practice pattern survey. (2013) (40)
Nonthyroidal illness and the cardiorenal syndrome (2013) (39)
Mechanisms of Endothelial Dysfunction in Resistance Arteries from Patients with End-Stage Renal Disease (2012) (39)
Recent insights in inflammation-associated wasting in patients with chronic kidney disease. (2011) (39)
Contribution of inflammation to vascular disease in chronic kidney disease patients. (2008) (39)
Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease (2014) (39)
Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation. (2011) (39)
Dialysis modality and nutritional status are associated with variability of inflammatory markers. (2016) (38)
Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study (2019) (38)
Biocompatibility of New Peritoneal Dialysis Solutions: What Can We Hope to Achieve? (2000) (38)
Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. (2006) (38)
Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type (2019) (38)
Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. (2009) (38)
Imbalance between Detached Circulating Endothelial Cells and Endothelial Progenitor Cells in Chronic Kidney Disease (2006) (37)
Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival. (2011) (37)
Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. (2005) (37)
Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. (2009) (37)
Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? (2013) (37)
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease (2018) (37)
Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients. (2010) (37)
Oral health and pro-inflammatory status in end-stage renal disease patients. (2007) (37)
Subclinical versus overt obesity in dialysis patients: more than meets the eye. (2013) (37)
Opposing Activity Changes in AMP Deaminase and AMP-Activated Protein Kinase in the Hibernating Ground Squirrel (2015) (37)
Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. (2008) (36)
Associations of Chronic Inflammation, Insulin Resistance, and Severe Obesity With Mortality, Myocardial Infarction, Cancer, and Chronic Pulmonary Disease (2019) (36)
Gene Polymorphism Association Studies in Dialysis: The Nutrition‐Inflammation Axis (2005) (35)
Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia. (1995) (35)
End‐stage renal disease: a state of chronic inflammation and hyperleptinemia (2003) (34)
Home hemodialysis: Beliefs, attitudes, and practice patterns (2014) (34)
Nrf2 in early vascular ageing: calcification, senescence and therapy. (2020) (34)
Classification of Uremic Toxins and Their Role in Kidney Failure. (2021) (34)
Dietary fat modification in patients with chronic kidney disease: n-3 fatty acids and beyond. (2013) (33)
Genetic approaches in the clinical investigation of complex disorders: malnutrition, inflammation, and atherosclerosis (MIA) as a prototype. (2003) (33)
Reduced skeletal muscle expression of mitochondrial derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease. (2019) (33)
Impaired resistance artery function in patients with end-stage renal disease. (2011) (33)
Prevalence and Risk of Protein-Energy Wasting Assessed by Subjective Global Assessment in Older Adults With Advanced Chronic Kidney Disease: Results From the EQUAL Study. (2018) (33)
Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. (2014) (33)
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy. (2006) (32)
Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3–5 chronic kidney disease (2015) (32)
Low cholesterol in dialysis patients--causal factor for mortality or an effect of confounding? (2011) (32)
Determinants and survival implications of low bone mineral density in end-stage renal disease patients. (2013) (32)
Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients. (2005) (32)
Activity-related energy expenditure of patients undergoing hemodialysis. (2011) (31)
Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers. (2001) (31)
IGF-1 and survival in ESRD. (2014) (31)
Why Do Dialysis Patients Develop a Heart of Stone and Bone of China? (2005) (31)
Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? (1998) (31)
Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk (2009) (31)
Regional variations in the relationship between arterial stiffness and adipocyte volume or number in obese subjects (2014) (31)
Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease (2015) (31)
Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease. (2002) (30)
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease (2016) (30)
Nutritional status of older patients on hemodialysis: Which nutritional markers can best predict clinical outcomes? (2019) (30)
Decreased Renal Clearance of Sodium in Cystic Fibrosis (1991) (30)
Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy (2005) (29)
TOF-SIMS analysis of adipose tissue from patients with chronic kidney disease (2008) (29)
Clostridium difficile infection--a poor prognostic sign in uremic patients? (1992) (29)
Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients. (2009) (29)
The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification. (2018) (29)
Allostatic load and ageing: linking the microbiome and nutrition with age-related health. (2019) (29)
Bone mineral density and mortality in end-stage renal disease patients (2020) (29)
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly (2015) (29)
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation (2012) (29)
PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research (2009) (28)
Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach. (2011) (28)
Bone Mineral Density in End-Stage Renal Disease Patients: Association with Wasting, Cardiovascular Disease and Mortality (2008) (28)
Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study (2019) (28)
Is Fetuin-A/α2-Heremans-Schmid Glycoprotein Associated with the Metabolic Syndrome in Patients with Chronic Kidney Disease? (2008) (28)
Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation? (2006) (27)
Biomimetics – Nature's roadmap to insights and solutions for burden of lifestyle diseases (2020) (27)
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis (2017) (27)
Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis. (2009) (27)
Interleukin-1 Gene Cluster Polymorphisms Are Associated with Nutritional Status and Inflammation in Patients with End-Stage Renal Disease (2005) (26)
The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications? (2009) (26)
LDL–apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion (2000) (26)
N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients (2008) (26)
Uraemic sera stimulate lipolysis in human adipocytes: role of perilipin. (2011) (26)
Resolved: being fat is good for dialysis patients: the Godzilla effect: con. (2008) (26)
C‐reactive Protein: Repeated Measurements will Improve Dialysis Patient Care (2016) (26)
Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease (2018) (26)
An Epidemiological Study of Hemodialysis Patients Based on the European Fresenius Medical Care Hemodialysis Network: Results of the ARO Study (2010) (26)
Obesity--a disease with many aetiologies disguised in the same oversized phenotype: has the overeating theory failed? (2015) (26)
Alport Syndrome Classification and Management (2020) (26)
Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. (1999) (25)
Cardiovascular biomarkers in chronic kidney disease. (2012) (25)
Epigenetics--a helpful tool to better understand processes in clinical nephrology? (2008) (25)
What are the causes of protein-energy malnutrition in chronic renal insufficiency? (2002) (25)
Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease (2018) (25)
Serum albumin, inflammation, and nutrition in end‐stage renal disease: C‐reactive protein is needed for optimal assessment (2018) (25)
Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study. (2006) (25)
The Association of Mediterranean and DASH Diets with Mortality in Adults on Hemodialysis: The DIET-HD Multinational Cohort Study. (2018) (24)
Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortality. (2012) (24)
Temporal discrepancies in the association between the apoB/apoA‐I ratio and mortality in incident dialysis patients (2009) (24)
The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. (2004) (23)
Erratum to: Wasting in chronic kidney disease (2011) (23)
Clostridium difficile-Associated diarrhoea in uremic patients (1987) (23)
Evaluation of the Association of Plasma Pentraxin 3 Levels with Type 2 Diabetes and Diabetic Nephropathy in a Malay Population (2013) (23)
Simple advice on lifestyle habits and long-term changes in biomarkers of inflammation and vascular adhesion in healthy middle-aged men (2010) (23)
Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study (2019) (23)
Can Treating Persistent Inflammation Limit Protein Energy Wasting? (2013) (23)
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection (2021) (23)
Factors influencing progression in patients with chronic renal failure (1989) (23)
Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease—A Novel Target for Treatment (2019) (23)
Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease. (2011) (22)
Rare progerin-expressing preadipocytes and adipocytes contribute to tissue depletion over time (2017) (22)
The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages (2018) (22)
Renal function in hypoxaemic chronic obstructive pulmonary disease: effects of long-term oxygen treatment. (2003) (22)
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome (2021) (22)
Inflammation and oxidative stress in CKD and dialysis patients. (2021) (22)
Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease. (2020) (22)
Temporal Associations Among Body Mass Index, Fasting Insulin, and Systemic Inflammation (2021) (22)
Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium (2020) (22)
Low‐density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome (1997) (22)
DNA Hypermethylation and Inflammatory Markers in Incident Japanese Dialysis Patients (2012) (22)
Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. (1997) (22)
Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: A double-blind, randomized, placebo-controlled trial (2018) (21)
Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease. (2013) (21)
Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease (2019) (21)
Long-lived animals with negligible senescence: clues for ageing research. (2019) (21)
Data Sharing Under the General Data Protection Regulation (2021) (21)
Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients (2015) (21)
Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency. (2009) (21)
Progress in Uremic Toxin Research: Genetics/Genomics in Chronic Kidney Disease—Towards Personalized Medicine? (2009) (20)
Being an inflamed peritoneal dialysis patient - a Dante's journey. (2006) (20)
Variations in C-reactive protein during a single haemodialysis session do not associate with mortality. (2010) (20)
Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4 (2014) (20)
Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study (2020) (19)
Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease. (2017) (19)
Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease. (2018) (19)
High‐density lipoprotein from end‐stage renal disease patients exhibits superior cardioprotection and increase in sphingosine‐1‐phosphate (2018) (19)
Bioactive food and exercise in chronic kidney disease: Targeting the mitochondria (2018) (19)
Associations between the CYBA 242C/T and the MPO –463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients (2007) (19)
Adipokines in Chronic Kidney Disease — Fat Tissue Gives Nephrologists a Message (2005) (19)
Effects of Hemodiafiltration on Uremic Inflammation (2013) (18)
A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells. (2007) (18)
Renal haemodynamics and tubular sodium handling following volume expansion with sodium chloride (NaCl) and glucose in healthy humans. (1992) (18)
Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study. (2019) (18)
Nonpharmacologic Strategies to Modulate Nuclear Factor Erythroid 2-related Factor 2 Pathway in Chronic Kidney Disease. (2017) (18)
Clinical determinants and mortality predictability of stearoyl‐CoA desaturase‐1 activity indices in dialysis patients (2013) (18)
Beyond the membrane--the role of new PD solutions in enhancing global biocompatibility. (2003) (17)
Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease (2011) (17)
Hypoalbuminemia: a price worth paying for improved dialytic removal of middle-molecular-weight uremic toxins? (2018) (17)
Nutrients and ageing: what can we learn about ageing interactions from animal biology? (2016) (17)
Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5 (2008) (17)
A distinct bone phenotype in ADPKD patients with end-stage renal disease. (2019) (17)
Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease (2010) (16)
Mitochondrial dysfunction and gut microbiota imbalance: An intriguing relationship in chronic kidney disease. (2019) (16)
To bee or not to bee? The bee extract propolis as a bioactive compound in the burden of lifestyle diseases. (2020) (16)
Place of genotyping and phenotyping in understanding and potentially modifying outcomes in peritoneal dialysis patients. (2006) (16)
Endostatin, Cathepsin S, and Cathepsin L, and Their Association with Inflammatory Markers and Mortality in Patients Undergoing Hemodialysis (2015) (16)
High Levels of Soluble Tumor Necrosis Factor Receptors 1 and 2 and Their Association with Mortality in Patients Undergoing Hemodialysis (2015) (16)
Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bears (2020) (16)
Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study. (2017) (16)
Major fractures after initiation of dialysis: Incidence, predictors and association with mortality. (2020) (16)
Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients (2013) (15)
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients (2018) (15)
Does the uremic milieu affect the epigenotype? (2009) (15)
Cranberries - potential benefits in patients with chronic kidney disease. (2019) (15)
Endocrine Aspects of Chronic Kidney Disease (2011) (15)
Methyl Donor Nutrients in Chronic Kidney Disease: Impact on the Epigenetic Landscape. (2019) (15)
Fractures after kidney transplantation: Incidence, predictors, and association with mortality. (2020) (14)
How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients? (2014) (14)
Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease. (2019) (14)
Identifying and Managing Malnutrition Stemming from Different Causes (2007) (14)
C-reactive protein--does it promote vascular disease? (2006) (14)
Impaired intrarenal dopamine production following intravenous sodium chloride infusion in Type 1 (insulin-dependent) diabetes mellitus (1991) (14)
From the distinctive smell to therapeutic effects: Garlic for cardiovascular, hepatic, gut, diabetes and chronic kidney disease. (2021) (14)
Epigenetics and the uremic phenotype: a matter of balance. (2008) (14)
Inflammation in chronic kidney disease (2022) (14)
Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients (2018) (13)
Adipokine signaling in the peritoneal dialysis patient. (2006) (13)
Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis. (2007) (13)
CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Homocysteine‐Lowering Is Not a Primary Target for Cardiovascular Disease Prevention in Chronic Kidney Disease Patients (2007) (13)
Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy (2016) (13)
Premature aging in chronic kidney disease and chronic obstructive pulmonary disease: similarities and differences (2015) (13)
Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort. (2020) (12)
Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients (2014) (12)
A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients (2015) (12)
Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients. (2007) (12)
Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder (2020) (12)
Nonphosphate‐Binding Effects of Sevelamer—Are They of Clinical Relevance? (2008) (12)
The enigma of decreased creatinine generation in acute kidney injury. (2012) (12)
Role of Uremic Toxins in Early Vascular Ageing and Calcification (2021) (11)
Role of Interleukin-1β in the Development of Malnutrition in Chronic Renal Failure Patients (2005) (11)
Understanding the role of genetic polymorphisms in chronic kidney disease (2008) (11)
Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis (2014) (11)
Current epigenetic aspects the clinical kidney researcher should embrace. (2017) (11)
Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy. (2005) (11)
Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients (2014) (11)
Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients (2016) (11)
A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease (2019) (11)
Low molecular weight heparin--does it favourably affect lipid levels? (1995) (11)
Life/2020—the future of kidney disease (2020) (11)
Systematic review of the nuclear factor erythroid 2-related factor 2 (NRF2) system in human chronic kidney disease: alterations, interventions, and relation to morbidity. (2021) (11)
Systemic and local inflammation in peritoneal dialysis: mechanisms, biomarkers and effects on outcome. (2009) (11)
Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction? (2020) (11)
OPTA—Influence of inflammation/infection on anaemia therapy in haemodialysis patients (2007) (10)
Genetic studies in chronic kidney disease: interpretation and clinical applicability. (2012) (10)
Manipulating the exposome to enable better ageing (2021) (10)
Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease. (2017) (10)
Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting. (2015) (10)
Chronic inflammation in PD patients. (2003) (10)
Peroxisome Proliferator-Activated Receptor-γ Agonists Diminish Peritoneal Functional and Morphological Changes Induced by Bioincompatible Peritoneal Dialysis Solution (2006) (10)
Telomere Attrition and Elongation after Chronic Dialysis Initiation in Patients with End-Stage Renal Disease (2015) (10)
Nutrition: Can ghrelin improve appetite in uremic wasting? (2009) (10)
Differences in acute metabolism of fructose between hemodialysis patients and healthy subjects (2013) (10)
Inflammation, Oxidative Stress, and Bone in Chronic Kidney Disease in the Osteoimmunology Era (2021) (10)
Phenotypic features of vascular calcification in chronic kidney disease (2019) (10)
Dietary Patterns and Mortality in a Multinational Cohort of Adults Receiving Hemodialysis. (2020) (10)
Can nutritional interventions modulate the activation of the NLRP3 inflammasome in chronic kidney disease? (2020) (10)
High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients (2020) (10)
PROGRESS IN UREMIC TAXIN RESEARCH: Leptin and Uremic Protein‐Energy Wasting—The Axis of Eating (2009) (9)
The sweet side of dark chocolate for chronic kidney disease patients. (2020) (9)
Stillbirth is associated with increased risk of long-term maternal renal disease: a nationwide cohort study (2020) (9)
Lipoprotein(a) in chronic renal disease. (1996) (9)
Methods and rationale of the DISCOVER CKD global observational study (2021) (9)
Could Low-Protein Diet Modulate Nrf2 Pathway in Chronic Kidney Disease? (2018) (9)
Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees (2020) (9)
Ageing - Oxidative stress, PTMs and disease. (2022) (9)
Hospitalization and mortality following non-attendance for hemodialysis according to dialysis day of the week: a European cohort study (2020) (9)
The value of the Brazilian açai fruit as a therapeutic nutritional strategy for chronic kidney disease patients (2018) (9)
Kidney biomimicry--a rediscovered scientific field that could provide hope to patients with kidney disease. (2013) (9)
TNF-α levels are not increased in inflamed patients carrying the CCR5 deletion 32. (2011) (9)
Novel insights from genetic and epigenetic studies in understanding the complex uraemic phenotype. (2014) (9)
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients (2019) (9)
Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study (2021) (9)
The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration – The Pan Thames Renal Audit (2010) (9)
Predialysis chronic kidney disease in 2010: Novel targets for slowing CKD progression (2011) (9)
Aortic Valve Calcium Associates with All-Cause Mortality Independent of Coronary Artery Calcium and Inflammation in Patients with End-Stage Renal Disease (2020) (9)
CDKN 2 A / p 16 INK 4 a expression is associated with vascular progeria in chronic kidney disease (8)
Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy (2019) (8)
Chapter 4 – Uremic Toxicity (2013) (8)
Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time (2017) (8)
Muscle Mass Assessed by Computed Tomography at the Third Lumbar Vertebra Predicts Patient Survival in Chronic Kidney Disease. (2020) (8)
The enigma of increasing serum leptin levels during peritoneal dialysis. (1999) (8)
Molecular genetics in renal medicine: what can we hope to achieve? (2002) (8)
Socioeconomic position links circulatory microbiota differences with biological age (2021) (8)
Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease. (2016) (8)
Determinants of N-Terminal Pro-Brain Natriuretic Peptide Variation in Hemodialysis Patients and Prediction of Survival (2014) (8)
Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality (2013) (8)
Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients (2017) (8)
Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased? (2012) (8)
Genetic studies in chronic kidney disease: basic concepts. (2012) (8)
Inflamed fat and mitochondrial dysfunction in end-stage renal disease links to hypoxia-could curcumin be of benefit? (2017) (8)
Effects of acute fructose loading on levels of serum uric acid—a pilot study (2018) (8)
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5 (2020) (7)
Nutritional Aspects of Adult Patients Treated With Chronic Peritoneal Dialysis Aspectos Nutricionais de Pacientes Adultos em Diálise Peritoneal (2006) (7)
Potential natural immunization against atherosclerosis in hibernating bears (2021) (7)
Implantation of Autologous Selected Renal Cells in Diabetic Chronic Kidney Disease Stages 3 and 4—Clinical Experience of a “First in Human” Study (2016) (7)
Risk of long-term renal disease in women with a history of preterm delivery: a population-based cohort study (2020) (7)
CHAPTER 78 – Cardiovascular Disease in Chronic Kidney Disease (2010) (7)
A Comparative Analysis of Nutritional Assessment Using Global Leadership Initiative on Malnutrition Versus Subjective Global Assessment and Malnutrition Inflammation Score in Maintenance Hemodialysis Patients. (2021) (7)
Inflammation as a target for improving health in chronic kidney disease (2010) (7)
Protein-Energy Malnutrition/Wasting During Peritoneal Dialysis (2009) (7)
Statins to Treat Chronic Inflammation in Dialysis Patients — is this Feasible? (2007) (7)
Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene? (2017) (7)
A novel bioactive haemodialysis system using dissolved dihydrogen (H 2 ) produced by water electrolysis: a clinical trial (2010) (7)
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study (2018) (7)
Is UCP2 gene polymorphism associated with decreased resting energy expenditure in nondialyzed chronic kidney disease patients? (2008) (7)
Reply to A Molfino et al (2007) (7)
Renal volumetry with magnetic resonance imaging (2017) (7)
Hypogonadism in males with chronic kidney disease: another cause of resistance to erythropoiesis-stimulating agents? (2012) (7)
Pro-Neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease. (2020) (7)
Physical activity promotes health also among dialysis patients. (2000) (7)
A biomimetic natural sciences approach to understanding the mechanisms of ageing in burden of lifestyle diseases. (2021) (6)
Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease—confounding and modifying effects of cardiovascular disease, body composition and inflammation (2017) (6)
A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis. (2021) (6)
[Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes]. (2003) (6)
Use of single-nucleotide polymorphisms in the search for genetic modifiers of the uremic phenotype. (2007) (6)
Effects of Bardoxolone Methyl in Alport Syndrome (2021) (6)
Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients. (2005) (6)
The role of epigenetics in kidney diseases. (2011) (6)
Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients. (2006) (6)
Insulin causes renal vasodilatation independently of renal prostaglandins in healthy humans. (1994) (6)
Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality (2020) (5)
Fabry Disease: A New Model of Premature Ageing? (2019) (5)
Prevention and treatment of the malnutrition, inflammation and atherosclerosis (MIA) syndrome in uremic patients. (2000) (5)
Intestinal alkaline phosphatase modulation by food components: predictive, preventive, and personalized strategies for novel treatment options in chronic kidney disease (2020) (5)
Adverse pregnancy outcomes and long-term risk of maternal renal disease: a systematic review and meta-analysis protocol (2019) (5)
Effects of dopamine on leptin release and leptin gene (OB) expression in adipocytes from obese and hypertensive patients (2013) (5)
Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality (2021) (5)
Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial (2022) (5)
Renal function and lipid metabolism are major predictors of circumpapillary retinal nerve fiber layer thickness—the LIFE-Adult Study (2021) (5)
Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes (2019) (5)
Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins (2022) (5)
Incidence of Fractures Before and After Dialysis Initiation (2020) (5)
Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method (2014) (5)
Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality (2020) (5)
New Strategies for Management of Malnutrition in Peritoneal Dialysis Patients (2000) (5)
Malnutrition in Patients with End-Stage Renal Disease - Anorexia,Cachexia and Catabolism (2007) (5)
Inflamed fat and mitochondrial dysfunction in end-stage renal disease links to hypoxia-could curcumin be of benefit? (2017) (5)
Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy (2022) (5)
Time‐dependent lipid profile inversely associates with mortality in hemodialysis patients – independent of inflammation/malnutrition (2021) (5)
[Strong connection between malnutrition, inflammation and arteriosclerosis. Improved treatment of renal failure if underlying factors are attacked]. (1999) (5)
A planetary health perspective for kidney disease (2020) (5)
High-sensitivity troponins in dialysis patients: variation and prognostic value (2020) (4)
Vascular calcification in chronic kidney disease (2009) (4)
Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis (2010) (4)
Emerging Role of Clinical Genetics in CKD (2022) (4)
Cardiovascular Disease Risk Factors in Chronic Kidney Disease: Traditional, Nontraditional, and Uremia-related Threats (2010) (4)
Inhibiting BTB domain and CNC homolog 1 (Bach1) as an alternative to increase Nrf2 activation in chronic diseases. (2022) (4)
Pink pressure: beetroot (Beta vulgaris rubra) as a possible novel medical therapy for chronic kidney disease. (2021) (4)
Effect of insulin on renal sodium handling and renal haemodynamics in insulin-dependent (type 1) diabetes mellitus patients (1995) (4)
The One Health concept – the health of humans is intimately linked with the health of animals and a sustainable environment (2020) (4)
Anorexia and Appetite Stimulants in Chronic Kidney Disease (2013) (4)
Adiponectin in chronic kidney disease: Dr Jekyll and Mr Hyde. (2009) (4)
The oxygen cascade in hemodialysis patients and native high altitude dwellers- Lessons from extreme physiology to benefit patients with end-stage renal disease. (2020) (4)
Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients. (2007) (4)
Survival on four compared with three times per week haemodialysis in high ultrafiltration patients: an observational study (2020) (3)
Scoring of medial arterial calcification predicts cardiovascular events and mortality after kidney transplantation (2022) (3)
Epidemiology and outcome - 2 (2009) (3)
The role of inflammation in chronic kidney disease (2015) (3)
SARS‐COV‐2 and biomimetics: What saves the planet will save our health (2020) (3)
[Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease]. (2014) (3)
505 Improvement of cardiac function after hemodialysis. Quantitative evaluation by colour tissue velocity imaging (TVI) (2003) (3)
Telomere biology alterations as a mortality risk factor in CKD. (2008) (3)
Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation. (2017) (3)
Non-thyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? (2014) (3)
Research update for articles published in EJCI in 2011 (2013) (3)
Short-term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy (1997) (3)
Is chronic renal disease always progressive? (1989) (3)
Osteomodulin attenuates smooth muscle cell osteogenic transition in vascular calcification (2022) (3)
Patient-Reported Measures and Lifestyle Are Associated With Deterioration in Nutritional Status in CKD Stage 4-5: The EQUAL Cohort Study. (2021) (3)
Design and methodology of the Aging Nephropathy Study (AGNES): a prospective cohort study of elderly patients with chronic kidney disease (2020) (2)
Planetary Health, Nutrition and Chronic Kidney Disease: Connecting the Dots for a Sustainable Future. (2022) (2)
Lipoprotein Lipase 1595 C/G and Hepatic Lipase –480 C/T Polymorphisms – Impact on Lipid Profile in Incident Dialysis Patients (2008) (2)
Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden. (2022) (2)
Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease (2022) (2)
The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study (2022) (2)
Fermented food: Should patients with cardiometabolic diseases go back to an early neolithic diet? (2022) (2)
Correction: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study (2019) (2)
ASSOCIATION OF FRUIT AND VEGETABLE INTAKE WITH ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS (DIET-HD): A PROSPECTIVE COHORT STUDY (2018) (2)
[The triple whammy of muscle loss, osteoporosis and vascular calcification in chronic kidney disease patients calls out the need for novel treatment strategies]. (2013) (2)
Iron Management in Chronic Kidney Disease : Report from a Kidney Disease : Improving Global Outcomes ( KDIGO ) Controversies Conference (2015) (2)
Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes (2020) (2)
MP431EFFECTS OF PROBIOTIC SUPPLEMENTATION ON UREMIC TOXINS LEVELS IN NON-DIALYSIS CKD PATIENTS (2017) (2)
Cardiovascular complications - 3 (2009) (2)
The 12th International Conference on Continuous Renal Replacement Therapies (CRRT). March 7–10, 2007, San Diego, Calif. (2007) (2)
Effects of microsomal prostaglandin E synthase‐1 inhibition on resistance artery tone in patients with end stage kidney disease (2021) (2)
Is Hyperhomocysteinemia a Contributor to Atherosclerosis in Chronic Kidney Disease Patients? (2005) (2)
Archaea from the gut microbiota of humans: Could be linked to chronic diseases? (2022) (1)
Protein-energy wasting, inflammation and oxidative stress (2009) (1)
MP666INFLAMMATION DOWN REGULATES CYTOCHROME P450 MEDINATED DRUG METABOLISM IN HEMODIALYSIS PATIENTS (2016) (1)
Inverse association of transferrin saturation with mortality risk in chronic kidney disease (2020) (1)
Resistant Starch Type-2 Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis Patients. (2022) (1)
Like total ghrelin, acylated ghrelin is also lower in HD patients with cardiovascular disease (2011) (1)
Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden – a decade of follow‐up (2021) (1)
Decreased concentrations of deoxycholic acid in serum of uraemic patients with diarrhoea. (1990) (1)
Does gestational diabetes increase the risk of maternal kidney disease? A Swedish national cohort study (2022) (1)
Low plasma insulin-like growth factor-1 associates with increased mortality in chronic kidney disease patients with reduced muscle strength. (2022) (1)
P300 MUSCLE ATROPHY, INFLAMMATION AND CLINICAL OUTCOME IN INCIDENT AND PREVALENT DIALYSIS PATIENTS (2008) (1)
Pregnancy‐associated plasma protein A and mortality in haemodialysis (2018) (1)
Protein-energy wasting, inflammation and oxidative stress (2009) (1)
Food for healthier aging: power on your plate. (2022) (1)
Brazil nut supplementation does not affect trimethylamine-n-oxide plasma levels in patients with coronary artery disease. (2022) (1)
POS-328 THE BURDEN OF HYPERKALEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2021) (1)
Acknowledgement to Referees (2006) (1)
Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure—A Tri-National Cohort (2022) (1)
Research update for articles published in EJCI in 2008 (2010) (1)
The obese patient (metabolic syndrome) (2015) (1)
Do metabolic derangements in end‐stage polycystic kidney disease differ versus other primary kidney diseases? (2018) (1)
Prize Orals (2017) (1)
Fructose might be a clue to the origin of preeclampsia insights from nature and evolution (2022) (1)
Short Report: Choline plasma levels are related to Nrf2 transcriptional expression in chronic kidney disease? (2022) (1)
PROGRESS IN UREMIC TOXIN RESEARCH: Conservative Treatment of the Uremic Syndrome (2009) (1)
Obesity in Kidney Disease (2019) (1)
Epidemiology and outcome research in CKD 5D (2012) (1)
Effects of Acute Fructose Loading on Markers of Inflammation—A Pilot Study (2021) (1)
Metabolic syndrome in combination with chronic kidney disease—It´s a gut feeling (2021) (1)
6th Update on Fabry Disease: Biomarkers, Progression and Treatment Opportunities (2019) (1)
Transcription factor NRF2 as potential therapeutic target for preventing muscle wasting in aging chronic kidney disease patients (2022) (1)
Peritoneal dialysis - clinical (2013) (1)
Peritoneal dialysis (2013) (0)
Implications of Senescent Cell Burden and NRF2 Pathway in Uremic Calcification: A Translational Study (2023) (0)
FP580MUSCLE STRENGTH, MUSCLE MASS AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS (2015) (0)
Treatment of malnutrition and anaemia (2011) (0)
CKD BONE DISEASE (2014) (0)
[The council for new therapies should immediately revoke their decision on eculizumab]. (2015) (0)
Biomimetics provides lessons from nature for contemporary ways to improve human health (2021) (0)
P1399SPARING EFFECT OF PERITONEAL DIALYSIS VS HEMODIALYSIS ON CHANGE OF BONE MINERAL DENSITY EVALUATED BY WHOLE-BODY DXA AFTER INITIATION OF DIALYSIS THERAPY AND ITS IMPACT ON CLINICAL OUTCOME (2020) (0)
MO009ROLE OF GDF-15, YKL-40, AND MMP-9 IN PATIENTS WITH ESKD: FOCUS ON SEX SPECIFIC ASSOCIATIONS WITH VASCULAR OUTCOMES AND ALL-CAUSE MORTALITY (2021) (0)
Subject Index Vol. 25, 1999 (1999) (0)
Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy (2022) (0)
MO550: Vascular Cells Senescence and Modifications in NRF2 Pathway in a Model of URaEMIC Vascular Calcification (2022) (0)
Warfarin treatment, kidney dysfunction and outcome in acute myocardial infarction patients with a history of atrial fibrillation (2013) (0)
The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison (2023) (0)
24th Annual Meeting of the International Society of Blood Purification (ISBP). September 8–10, 2006, Nara, Japan (2006) (0)
Contents Vol. 40, No. 4, 2015 (2015) (0)
MP383LOW BONE MINERAL DENSITY OF LEGS AND FEMORAL NECK ASSOCIATES WITH CORONARY CALCIFICATION SCORE IN FEMALE END-STAGE RENALDISEASE PATIENTS (2016) (0)
Biomimetik [Biomimetics] : att efterlikna naturen for att forebygga sjukdom [imitating nature to prevent disease] (2015) (0)
Mechanisms of progression and CVD-CKD interaction FO006 SERUM VISFATIN CONCENTRATION AND ENDOTHELIAL DYSFUNCTION IN CHRONIC KIDNEY DISEASE FO008 N-ACETYLCYSTEINE PROTECTS AGAINST BILATERAL URETERAL OBSTRUCTION (2007) (0)
MO489GESTATIONAL DIABETES AND THE LONG-TERM RISK OF MATERNAL KIDNEY DISEASE: A SWEDISH NATIONAL COHORT STUDY (2021) (0)
3rd Basic Multidisciplinary Hemodialysis Access Course (2000) (0)
FP559ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS (2015) (0)
Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality (2021) (0)
Adverse pregnancy outcomes and long-term risk of maternal renal disease: a systematic review (2019) (0)
Secular trends in hip fracture incidence and subsequent mortality in dialysis patients and the general population in Sweden. (2021) (0)
Nonthyroidal illness and the cardiorenal (2013) (0)
FC 123RENAL TRANSPLANTATION MITIGATES INCREASED BIOLOGICAL (EPIGENETIC) AGE IN CHRONIC KIDNEY DISEASE (2021) (0)
[Acute renal failure can be prevented. New discoveries on the significance of hypoxia in the renal medulla]. (1995) (0)
Lessons from evolution by natural selection: An unprecedented opportunity to use biomimetics to improve planetary health. (2022) (0)
P1389MAJOR OSTEOPOROTIC FRACTURES AFTER INITIATION OF DIALYSIS: INCIDENCE, PREDICTORS AND ASSOCIATION WITH MORTALITY (2020) (0)
DIFFERENT ACUTE METABOLISM OF FRUCTOSE IN DIALYSIS PATIENTS COMPARED TO HEALTHY SUBJECTS (2012) (0)
[Unknown public disease is becoming more prevalent]. (2013) (0)
Fat oxidation is activated in liver during hibernation. (2015) (0)
MO455LIPID PROFILE AND UREMIC RETENTION SOLUTES IN PATIENTS WITH END-STAGE KIDNEY DISEASE (2021) (0)
Is there a link between inflammation, plasma resistin levels, and protein malnutrition in hemodialysis patients? Authors' reply (2006) (0)
SP564HIGH SENSITIVE TROPONIN T AND TROPONIN I THREE MONTH VARIATION IN PREVALENT HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS (2015) (0)
Preeclampsia and the risk of chronic kidney disease: a national registry-based cohort study (2020) (0)
MP440OBSTRUCTIVE AND RESTRICTIVE LUNG FUNCTION ASSOCIATES WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2017) (0)
MO056MODIFICATION OF P16, P21 AND NRF2 EXPRESSION IN A MODEL OF UREMIC VASCULAR CALCIFICATION (2020) (0)
Changes in bone-mineral parameters predict subsequent mortality in hemodialysis patients insights from the european aro-cohort (2018) (0)
Ageing – Oxidative stress, PTMs and disease Molecular Aspects of Medicine (2022) (0)
Phosphate depletion in insulin-insensitive skeletal muscle drives AMPD activation and sarcopenia in chronic kidney disease (2023) (0)
SO059CIRCULATING PROTEINS AS PREDICTORS OF CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS - A PROTEOMIC APPROACH (2017) (0)
FC020BONE MINERAL DENSITY AT VARIOUS SITES VERSUS MORTALITY IN END-STAGE RENAL DISEASE (ESRD) (2019) (0)
MO673: Association of Mean Corpuscular Volume with Mortality in Kidney Failure Patients: Opposite Findings in Chinese and Swedish Kidney Failure Patients (2022) (0)
Testosterone concentrations andoutcomes in hemodialysis patients of the EVOLVE trial. (2022) (0)
Telomere shortening, a new mortality risk factor in dialysis patients. Associations with inflammatory markers and fetuin-a levels (2007) (0)
Hormonal status in critically ill patients with or without acute renal failure (1998) (0)
Author Index to Abstracts (2002) (0)
International conference on dialysis III (2001) (0)
FP336EPICARDIAL FAT ACCUMULATION, CARDIOMETABOLIC PROFILE AND CARDIOVASCULAR EVENTS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE (2015) (0)
[Unusual but serious adverse effect. Epoetin treatment of patients with kidney diseases caused erythroblastopenia]. (2002) (0)
OP67 Hypertensive disorders of pregnancy and the risk of chronic kidney disease: a national registry-based cohort study (2020) (0)
P63 Adverse pregnancy outcomes and long-term risk of maternal renal disease: a systematic review and meta-analysis (2019) (0)
POS-503 EVALUATING CHRONIC KIDNEY DISEASE PROGRESSION: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2021) (0)
CKD NUTRITION, INFLAMMATION AND OXIDATIVE STRESS (2014) (0)
SO072INCIDENCE OF FRACTURES BEFORE AND AFTER DIALYSIS INITIATION AMONG INCIDENT DIALYSIS PATIENTS (2020) (0)
FP336HIGHER NEUTROPHIL TO LYMPHOCYTE RATIO ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS (2018) (0)
No association between plasma total homocysteine and common carotid intima thickness in end-stage renal disease patients (2002) (0)
Table of Contents (2020) (0)
18th Annual Meeting of the International Society of Blood Purification (2000) (0)
MO439NATURAL IMMUNISATION AGAINST ATHEROSCLEROSIS IN BEARS DURING HIBERNATION* (2021) (0)
Response to ‘Resistin letters’ (2006) (0)
Combination of Preoperative CT and Carotid Plaque Gene Expression Profiling Demonstrates an Association Between Calcification and Plaque‐Stabilizing Processes: FT19. (2017) (0)
FP392DYNAMIC PREDICTION OF MORTALITY IN ADVANCED CKD USING TROPONIN T (2019) (0)
Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease (2011) (0)
[Selection of dialysis type--a crucial decision. Peritoneal dialysis is better for the patient and cheaper for the society]. (2005) (0)
Cinnamon: an aromatic condiment applicable to chronic kidney disease (2023) (0)
Consumption of Fish in Chronic Kidney Disease - A Matter of Depth. (2023) (0)
Faculty Opinions recommendation of Antiproteinuric effect of oral paricalcitol in chronic kidney disease. (2006) (0)
[Vascular calcification: a common but overlooked condition]. (2013) (0)
MO580: Healthy Plant-Based Diet for Patients With Chronic Kidney Disease (CKD) Through Use of Sodium Zirconium Cyclosilicate (SZC): A Feasibility Study (Helpful) (2022) (0)
A. SALT AND RELATED ISSUES FO001 SODIUM AND CHLORIDE CONCENTRATION OF SWEAT CORRELATE WITH DIETARY SALT INTAKE IN HEALTHY SUBJECTS (2018) (0)
The magical smell and taste: Can coffee be good to patients with cardiometabolic disease? (2022) (0)
TOF-SIMS analysis of adipose and muscle tissue from patients with chronic kidney disease (2008) (0)
Subject Index Vol. 26, 2008 (2008) (0)
Chronic Kidney Disease: Need for an Integrated Therapy Against Malnutrition and Wasting (2005) (0)
P1409HIP FRACTURE TRENDS IN SWEDISH GENERAL POPULATION AND DIALYSIS PATIENTS (2020) (0)
Vascular Effects of Inflammation and Oxidative Stress in CKD (2015) (0)
FP361PREDICTORS OF VASCULAR CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS (2019) (0)
Contents Vol. 26, 2008 (2008) (0)
Faculty Opinions recommendation of Klotho deficiency causes vascular calcification in chronic kidney disease. (2011) (0)
Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel Therapies (2023) (0)
Captured brown bear in its den. (2013) (0)
Reply (2006) (0)
Faculty Opinions recommendation of Socioeconomic deprivation is independently associated with mortality post kidney transplantation. (2013) (0)
Faculty Opinions recommendation of Phosphorus binders and survival on hemodialysis. (2010) (0)
Cardiovascular Disease and Inflammation (2021) (0)
Reply letter- critical comments on the impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study. (2021) (0)
Gender dimension in cardio-pulmonary continuum (2022) (0)
Contents Vol. 39, 2015 (2015) (0)
FC060THE ASSOCIATION BETWEEN FOUR TIMES A WEEK COMPARED TO THREE TIMES A WEEK HAEMODIALYSIS AND SURVIVAL, HOSPITALISATION AND VASCULAR ACCESS COMPLICATIONS IN EUROPEAN IN-CENTRE PATIENTS (2019) (0)
Ultraprocessed food and chronic kidney disease - double trouble (2023) (0)
MO681: Association of Framingham Risk Score with Mortality in Kidney Failure Patients from China and Sweden (2022) (0)
FP662THE ASSOCIATION OF MEDITERRANEAN AND DASH DIETS WITH MORTALITY IN ADULTS ON HEMODIALYSIS: THE DIET-HD MULTINATIONAL COHORT STUDY (2018) (0)
Faculty Opinions recommendation of Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. (2009) (0)
SO083VASCULAR STIFFNESS ESTIMATED NON-INVASIVELY USING PULSE WAVE PROPAGATION CORRESPONDS TO VASCULAR BIOPSY FINDINGS (2020) (0)
Estimated hepatic and adipose tissue stearoyl-coa desaturase-1 activities are associated with inflammation and all-cause mortality in dialysis patients (2012) (0)
Associations of Biopterins and ADMA with Vascular Function in Peripheral Microcirculation from Patients with Chronic Kidney Disease (2023) (0)
Contents Vol. 101, 2005 (2005) (0)
Acknowledgement to Referees (2008) (0)
Testosterone deﬁciency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease (2012) (0)
Subject Index Vol. 24, 2006 (2006) (0)
Homocysteine and reverse epidemiology. Authors' reply (2007) (0)
Protein-Energy Wasting/Malnutrition and the Inflammatory Response (2020) (0)
Paper Selection Committee (2010) (0)
SP402PENTOSIDINE IN END-STAGE RENAL DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) VERSUS OTHER ETIOLOGIES (2019) (0)
Iron management in chronic kidney disease: Global Outcomes” (KDIGO) Controversies Conference (2015) (0)
SP284BETA-TRACE PROTEIN CORRELATES WITH ENDOTHELIAL FUNCTION IN PERIPHERAL RESISTANCE ARTERIES IN END STAGE RENAL DISEASE (2017) (0)
MP311 EFFECT OF INCREASED ULTRAFILTRATION ON B-TYPE NATRIURETIC PEPTIDE (BNP) AND C-REACTIVE PROTEIN (CRP): DOES HYPERVOLEMIA MEDIATES CARDIAC DYSFUNCTION AND INFLAMMATION IN HEMODIALYSIS (2005) (0)
PP112-MON SELF-RATED APPETITE IS A POOR PREDICTOR OF MORTALITY IN PRE-DIALYSIS AND DIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) (2011) (0)
P0714RELATIONSHIP BETWEEN BIOLOGICAL AGE ESTIMATED BY SKIN AUTOFLUORESCENCE, CHRONOLOGICAL AGE, AND MORTALITY IN CHRONIC KIDNEY DISEASE (2020) (0)
Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease (2020) (0)
TO024COMBINATION OF GENOTYPE AND PHENOTYPE FEATURES AS PREDICTORS OF INFLAMMATION, CARDIOVASCULAR DISEASE AND PROTEIN ENERGY WASTING IN PATIENTS WITH CHRONIC KIDNEY DISEASES (2017) (0)
Faculty Opinions recommendation of Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. (2007) (0)
Muscle fat infiltration in chronic kidney disease: a marker related to muscle quality, muscle strength and sarcopenia (2023) (0)
Sodium and insulin--is there a relationship? (1995) (0)
MO025ARTERIAL GENE EXPRESSION SIGNATURES FOR SIRTUINS AND KLOTHO ASSOCIATE WITH BIOPSY VERIFIED ARTERIAL CALCIFICATION IN END-STAGE RENAL DISEASE (2017) (0)
MP429SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL STATUS AS PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS (2017) (0)
Health related quality of life and life-style factors are associated with decline in nutritional status in older adults with chronic kidney disease; the equal study (2018) (0)
Subject Index Vol. 101, 2005 (2005) (0)
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients (2018) (0)
SP286PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION (2016) (0)
[Ghrelin--new promising treatment in anorexia and catabolic conditions]. (2010) (0)
FP630ASSOCIATION OF FRUIT AND VEGETABLE INTAKE WITH ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS (DIET-HD): A PROSPECTIVE COHORT STUDY (2018) (0)
Title : Inflammation and premature aging in advanced chronic kidney disease 1 (2017) (0)
MO445 BRAIN AND GUT AXIS IN CHRONIC KIDNEY DISEASE: FOCUS ON SPECIFIC BIOMARKERS, AND TIGHT JUNCTION PROTEINS (2021) (0)
SP429CIRCULATING PLASMA PENTOSIDINE IN PRE-DIALYSIS, PRE-TRANSPLANT, PERITONEAL DIALYSIS (PD) AND HEMODIALYSIS (HD) PATIENTS (PTS) (2015) (0)
FC061DIETARY PATTERNS AND MORTALITY IN ADULTS ON HEMODIALYSIS (2019) (0)
Premature vascular aging and senescence in chronic kidney disease (0)
Nutritional screening and nutritional management in dialysis patients (2015) (0)
P0669HIGH ESTIMATED PHENOTYPIC AGE ASSOCIATES WITH WORSE CLINICAL OUTCOME IN CHRONIC KIDNEY DISEASE PATIENTS (2020) (0)
Plasma Lipoprotein(a) Is Related to Peritoneal Albumin Losses (1997) (0)
Why not turn "Food Deserts" at medical conferences into educational tools for a sustainable future? (2023) (0)
Title Pages / Contents (1999) (0)
Rare progerin-expressing preadipocytes and adipocytes contribute to tissue depletion over time (2017) (0)
Do changes in dietary and exercise habits in order to reduce cholesterol levels affect serum levels of inflammatory adhesion molecules (2000) (0)
SP356PULMONARY DYSFUNCTION IS LINKED TO MALNUTRITION AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS (2016) (0)
SP298HIGHER MEAN CORPUSCULAR VOLUME ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS (2018) (0)
A calcium-channel blocker, amlodipine, attenuates insulin antinatriuresis but does not modulate insulin-mediated attenuation of cardiovascular reactivity in healthy man. (1997) (0)
The Impact of Occasional vs Persistent Inflammation on the Survival of HD Patients (2003) (0)
Cardiovascular complications - 2 (2009) (0)
Blood–Brain Barrier Biomarkers before and after Kidney Transplantation (2023) (0)
Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review (2023) (0)
Chronic Kidney Disease and the Exposome of Ageing. (2023) (0)
Systemic inflammation in hemodialysis patients is associated with increased oxidation of the nucleotide pool as revealed by serum levels of 8oxo-dG (2005) (0)
High all cause and CVD mortality in an incident cohort of hemodialysis patients with low serum albumin and inflammation (2018) (0)
[New and old methods for the determination of renal function. More effective treatment requires better examinations]. (1993) (0)
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability (2010) (0)
Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type (2019) (0)
MO069SARS-COV-2 RECEPTOR ACE-2, TMPRSS2 AND SOLUBLE ACE-2 IN PATIENTS WITH END STAGE KIDNEY DISEASE (2021) (0)
Contents Vol. 24, 2006 (2006) (0)
Faculty Opinions recommendation of A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. (2006) (0)
MO445BRAIN AND GUT AXIS IN CHRONIC KIDNEY DISEASE: FOCUS ON SPECIFIC BIOMARKERS, AND TIGHT JUNCTION PROTEINS (2021) (0)
MO035INFLAMMATION MODIFIES THE MORTALITY PREDICTIVE CAPACITY OF OXIDATIVE DNA DAMAGE IN CHRONIC KIDNEY DISEASE PATIENTS (2017) (0)
MP449EFFECT OF LOW PROTEIN DIET ON TRIMETHYLAMINE-N-OXIDE PLASMA LEVELS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS (2017) (0)
Anaemia in CKD 5D (2011) (0)
Serum Thyrotropin Elevation and Coronary Artery Calcification in Hemodialysis Patients. (2022) (0)
Clinicaldeterminantsandmortalitypredictabilityof stearoyl-CoAdesaturase-1activityindicesindialysispatients (2012) (0)
Similar Increase Plasma Asymmetric Dimethylarginine (P‐ADMA) and in Non Renal patients with Abnormal Myocardial Perfusion and in Hemodialysis Patients. (2003) (0)
[The importance of weighing yourself regularly. Dr. Fox and the weight curve]. (2014) (0)
P1415PARATHYROIDECTOMY IMPROVES MUSCULAR FUNCTION BUT NOT MUSCLE MASS IN HEMODIALYSIS PATIENTS WITH SEVERE HYPERPARATHYROIDISM (2020) (0)
[The council for new therapies position on eculizumab is unacceptable]. (2015) (0)
The variation in hospitalisation and mortality following non-attendance for haemodialysis according to dialysis day of the week in a european cohort : further evidence of harm from the two-day break in three times a week haemodialysis (2018) (0)
Contents Vol. 25, 1999 (1999) (0)
Indoxyl Sulphate Retention Is Associated with Microvascular Endothelial Dysfunction after Kidney Transplantation (2023) (0)
Dysbiosis in Patients with Chronic Kidney Disease: Let Us Talk About Vitamin K. (2022) (0)
P0791MATRIX GLA PROTEIN AND PREMATURE VASCULAR CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE (2020) (0)
SP242GLOMERULAR FILTRATION RATE ESTIMATION USING BETA TRACE PROTEIN: EXTERNAL VALIDATION OF THREE EQUATIONS (2016) (0)
MO441CALPROTECTIN IS A NOVEL CONTRIBUTING FACTOR IN VASCULAR CALCIFICATION AND A PREDICTOR OF CARDIOVASCULAR OUTCOME IN CKD PATIENTS* (2021) (0)
Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients (2018) (0)
P0673INVERSE ASSOCIATION OF TRANSFERRIN SATURATION WITH MORTALITY RISK IN CHRONIC KIDNEY DISEASE (2020) (0)
Chronickidneydisease:apublichealthpriorityandharbinger ofprematurecardiovasculardisease (2010) (0)
Pathophysiology and clinical studies in CKD 5D (2011) (0)
Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study (2022) (0)
Resolved: Being Fat Is Good for Dialysis Patients: The Godzilla Effect: Con. (2008) (0)
Faculty Opinions recommendation of Kidney disease and increased mortality risk in type 2 diabetes. (2013) (0)
Cardiovascular complications of CKD 2 vi 311 Cardiovascular complications of CKD 2 SaP 234 (2007) (0)
PP111-MON SERUM ALBUMIN (S-ALB) AS PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN END-STAGE RENAL DISEASE (ESRD) PATIENTS (PTS) (2011) (0)
Increased lipoprotein binding to arterial proteoglycans and normal macrophage cholesterol efflux capacity define the pro-atherogenic feature of CKD dyslipidemia (2016) (0)
Correction to: Why not turn "Food Deserts" at medical conferences into educational tools for a sustainable future? (2023) (0)
MO454: Increased Senescent Cell Burden and Alterations in NRF2 Pathway Drive Uraemic Vascular Calcification in Humans (2022) (0)
MP738BONE MINERAL DENSITY IN LIVING DONOR RENAL TRANSPLANTATION RECIPENTS ASSOCIATES WITH FIBROBLAST GROWTH FACTOR23 (2016) (0)
ChemR 23 induces smooth muscle cell phenotypic switching to stimulate vascular calcification (2019) (0)
Faculty Opinions recommendation of Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. (2011) (0)
Osteomodulin is a novel gene in cardiovascular calcification (2021) (0)
Gene Expression Analysis in Inflamed and Non-inflamed Hemodialysis (HD) Patients Using a cDNA Microarray (2003) (0)
Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients (2023) (0)
Complications in End Stage Renal Disease – Focus on Expression and Variations of Candidate Susceptibility Genes (2005) (0)
MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts (2022) (0)
Subject Index Vol. 29, 2009 (2009) (0)
[Dialysis is life-sustaining--but when to initiate it?]. (2002) (0)
[Biomimetics--imitating nature to prevent disease]. (2015) (0)
Protein-energy wasting, inflammation and oxidative stress in CKD 5D (2011) (0)
’ s response to reviews Title : Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients (2019) (0)
Contents Vol. 29, 2009 (2009) (0)
OP-NDTJ200001 1157..1162 (2020) (0)
P0941HEALTHY K-RICH DIET IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS USING SODIUM ZIRCONIUM CYCLOSILICATE (SZC) TO CONTROL HYPERKALEMIA: A FEASIBILITY STUDY (HELPFUL) (2020) (0)
Nutritional management of chronic peritoneal dialysis patients (2022) (0)
List of Contributors (2019) (0)
SP323HIGH FIBRINOGEN LEVELS ARE INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) (2018) (0)
POS-305 HOSPITALIZATIONS AND LENGTH OF STAY IN PATIENTS WITH CKD WITH AND WITHOUT HYPERKALEMIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2022) (0)
P0887MAJOR OSTEOPOROTIC FRACTURES AFTER KIDNEY TRANSPLANTATION: INCIDENCE, PREDICTORS AND ASSOCIATION WITH MORTALITY (2020) (0)
SP019IS END-STAGE POLYCYSTIC KIDNEY DISEASE ASSOCIATED WITH IMPAIRMENT OF GLUCOSE METABOLISM? (2016) (0)
Prediction of Gastrointestinal Bleeding Hospitalization in Hemodialysis (2023) (0)
Proposal for a New Classification of Solutes of Interest in Uremia and Hemodialysis (2022) (0)
The Influence of C‐Hepatitis on C‐Reactive Protein in a Cohort of Brazilian Hemodialysis Patients (2004) (0)
[Cardiovascular disease increases the risk of renal failure]. (2007) (0)
Progression & risk factors CKD 1-5 (2) (2011) (0)
MP528SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS (2016) (0)
SO042WHOLE GENOME SEQUENCING OF HUMAN KIDNEY PROGENITORS IDENTIFIES A MUTATION-PRONE CELL TYPE IN THE PROXIMAL TUBULE (2020) (0)
POS-329 TREATMENT PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERKALEMIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2021) (0)
Front & Back Matter (2012) (0)
808-P: Association between Analogue Compared with Human Insulin and the Outcomes of Mortality, Hospitalization, MACE, and Hypoglycemia in Hemodialysis Patients with Type 2 Diabetes: The ARO Research Initiative (2022) (0)
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients (2019) (0)
Preterm delivery is associated with long-term risk of maternal renal disease (2019) (0)
SAT-200 INCREASED RISK OF LONG-TERM RENAL DISEASE IN WOMEN WHO DELIVER PRETERM INFANTS: A POPULATION-BASED COHORT STUDY (2020) (0)
FO002FIBROBLAST GROWTH FACTOR 23 IS ASSOCIATED WITH FRACTIONAL SODIUM EXCRETION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2018) (0)
The role of peritoneal dialysis in renal replacement therapy: an update on medical aspects. (2005) (0)
SP283IN VIVO AND EX VIVO ASSESSMENT OF MICROVASCULATURE FUNCTION IN RENAL TRANSPLANT RECIPIENTS FROM A LIVING DONOR (2017) (0)
Author Index/Subject Index Proceedings (2002) (0)
BATTRE BEHANDLING AV NJURSVIKT OM FAKTORERNA BAKOM ANGRIPS (1999) (0)
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter Stenvinkel?

Peter Stenvinkel is affiliated with the following schools:

University of Oviedo
Karolinska Institute

Peter Stenvinkel's Academic­Influence.com Rankings

Why Is Peter Stenvinkel Influential?

Peter Stenvinkel's Published Works

Published Works

What Schools Are Affiliated With Peter Stenvinkel?

Peter Stenvinkel's AcademicInfluence.com Rankings